Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nestl, A.
Right arrow Articles by Sleeman, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nestl, A.
Right arrow Articles by Sleeman, J. P.
[Cancer Research 61, 1569-1577, February 15, 2001]
© 2001 American Association for Cancer Research


Molecular Biology and Genetics

Gene Expression Patterns Associated with the Metastatic Phenotype in Rodent and Human Tumors1

Andrea Nestl2, Oliver D. Von Stein, Kurt Zatloukal, Wolf-Gerolf Thies, Peter Herrlich, Martin Hofmann3 and Jonathan P. Sleeman4

Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics [A. N., O. D. V. S., W-G. T., P. H., M. H., J. P. S.] and University of Karlsruhe, Institute of Genetics [P. H.], D-76021 Karlsruhe, Germany, and University of Graz, Department of Pathology, Division of Experimental Cell Research and Oncology, A-8036 Graz, Austria [K. Z.]

Using subtractive technology, we have generated metastasis-associated gene expression profiles for rat mammary and pancreatic adenocarcinomas. Several genes whose expression is thought to be related to tumor progression such as c-Met, urokinase-type plasminogen activator receptor, ezrin, HMG-1, oncomodulin, cathepsin, and caveolin were thereby isolated. Half of the metastasis-associated clones showed no significant homology to genes with known function. Notably, several of the metastasis-associated clones were also expressed in metastatic lines but not in nonmetastatic lines of other tumor models. Furthermore, in situ hybridization using selected clones documents the relevance of these results for human cancer because strong expression in tumor cells including metastases was detected in human colorectal cancer samples and, to a lesser extent, in mammary cancer samples. These data support the concept that tumors express a "metastatic program" of genes.




This article has been cited by other articles:


Home page
GutHome page
H M Kocher, J Sandle, T A Mirza, N F Li, and I R Hart
Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells
Gut, February 1, 2009; 58(2): 271 - 284.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. L. Styers, A. K. O'Connor, R. Grabski, E. Cormet-Boyaka, and E. Sztul
Depletion of {beta}-COP reveals a role for COP-I in compartmentalization of secretory compartments and in biosynthetic transport of caveolin-1
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1485 - C1498.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yamashita, S. Takahashi, N. McDonell, N. Watanabe, T. Niwa, K. Hosoya, Y. Tsujino, T. Shirai, and T. Ushijima
Methylation Silencing of Transforming Growth Factor-{beta} Receptor Type II in Rat Prostate Cancers
Cancer Res., April 1, 2008; 68(7): 2112 - 2121.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Monni, L. Haddaoui, A. Naba, I. Gallais, M. Arpin, P. Mayeux, and F. Moreau-Gachelin
Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia
Blood, March 15, 2008; 111(6): 3163 - 3172.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Yang, H. Avila, H. Wang, J. Trevino, G. E. Gallick, Y. Kitadai, T. Sasaki, and D. D. Boyd
Plasticity in Urokinase-Type Plasminogen Activator Receptor (uPAR) Display in Colon Cancer Yields Metastable Subpopulations Oscillating in Cell Surface uPAR Density--Implications in Tumor Progression
Cancer Res., August 15, 2006; 66(16): 7957 - 7967.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Lugini, P. Matarrese, A. Tinari, F. Lozupone, C. Federici, E. Iessi, M. Gentile, F. Luciani, G. Parmiani, L. Rivoltini, et al.
Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells.
Cancer Res., April 1, 2006; 66(7): 3629 - 3638.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Yu, E. Davicioni, T. J. Triche, and G. Merlino
The Homeoprotein Six1 Transcriptionally Activates Multiple Protumorigenic Genes but Requires Ezrin to Promote Metastasis
Cancer Res., February 15, 2006; 66(4): 1982 - 1989.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K Volp, M-L Brezniceanu, S Bosser, T Brabletz, T Kirchner, D Gottel, S Joos, and M Zornig
Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas
Gut, February 1, 2006; 55(2): 234 - 242.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Baumann, N. Cremers, F. Kroese, G. Orend, R. Chiquet-Ehrismann, T. Uede, H. Yagita, and J. P. Sleeman
CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis
Cancer Res., December 1, 2005; 65(23): 10783 - 10793.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Weichert, C. Denkert, M. Burkhardt, T. Gansukh, J. Bellach, P. Altevogt, M. Dietel, and G. Kristiansen
Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival
Clin. Cancer Res., September 15, 2005; 11(18): 6574 - 6581.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. W. Bauer, W. Liu, F. Fan, E. R. Camp, A. Yang, R. J. Somcio, C. D. Bucana, J. Callahan, G. C. Parry, D. B. Evans, et al.
Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met- and Insulin-like Growth Factor-I Receptor-Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice
Cancer Res., September 1, 2005; 65(17): 7775 - 7781.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Heiska and O. Carpen
Src Phosphorylates Ezrin at Tyrosine 477 and Induces a Phosphospecific Association between Ezrin and a Kelch-Repeat Protein Family Member
J. Biol. Chem., March 18, 2005; 280(11): 10244 - 10252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. M. Williams and M. P. Lisanti
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Am J Physiol Cell Physiol, March 1, 2005; 288(3): C494 - C506.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, L. Yang, Md. S. Jamaluddin, and D. D. Boyd
The Kruppel-like KLF4 Transcription Factor, a Novel Regulator of Urokinase Receptor Expression, Drives Synthesis of This Binding Site in Colonic Crypt Luminal Surface Epithelial Cells
J. Biol. Chem., May 21, 2004; 279(21): 22674 - 22683.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. D. Boyd, H. Wang, H. Avila, N. U. Parikh, H. Kessler, V. Magdolen, and G. E. Gallick
Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes in Vitro Colon Cancer Invasiveness
Clin. Cancer Res., February 15, 2004; 10(4): 1545 - 1555.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Fieber, P. Baumann, R. Vallon, C. Termeer, J. C. Simon, M. Hofmann, P. Angel, P. Herrlich, and J. P. Sleeman
Hyaluronan-oligosaccharide-induced transcription of metalloproteases
J. Cell Sci., January 15, 2004; 117(2): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Li, C. H. Ren, S. A. Tahir, C. Ren, and T. C. Thompson
Caveolin-1 Maintains Activated Akt in Prostate Cancer Cells through Scaffolding Domain Binding Site Interactions with and Inhibition of Serine/Threonine Protein Phosphatases PP1 and PP2A
Mol. Cell. Biol., December 15, 2003; 23(24): 9389 - 9404.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Wang, J. Hicks, P. Khanbolooki, S.-J. Kim, C. Yan, Y. Wang, and D. Boyd
Transgenic Mice Demonstrate Novel Promoter Regions for Tissue-Specific Expression of the Urokinase Receptor Gene
Am. J. Pathol., August 1, 2003; 163(2): 453 - 464.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Poser, M. Golob, R. Buettner, and A. K. Bosserhoff
Upregulation of HMG1 Leads to Melanoma Inhibitory Activity Expression in Malignant Melanoma Cells and Contributes to Their Malignancy Phenotype
Mol. Cell. Biol., April 15, 2003; 23(8): 2991 - 2998.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
V. Orian-Rousseau, L. Chen, J. P. Sleeman, P. Herrlich, and H. Ponta
CD44 is required for two consecutive steps in HGF/c-Met signaling
Genes & Dev., December 1, 2002; 16(23): 3074 - 3086.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Stapleton, A. Malliri, and B. W. Ozanne
Downregulated AP-1 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells
J. Cell Sci., January 7, 2002; 115(13): 2713 - 2724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.